Surgical Robotics

Modern surgical robots consist of several integrated technology layers. Articulated robotic arms provide 7 degrees of freedom (more than the human wrist), enabling surgical maneuvers impossible with traditional instruments. 3D HD/4K stereoscopic visualization with 10-15x magnification gives surgeons a view far superior to the naked eye. Force feedback (newly available in da Vinci 5) provides tactile sensation through the robotic instruments, allowing surgeons to feel tissue resistance. AI-powered surgical planning uses preoperative CT and MRI imaging to create patient-specific 3D models that guide the surgery in real time. Computer navigation tracks instrument position relative to patient anatomy with sub-millimeter accuracy. Simulation platforms provide virtual reality surgical training with realistic tissue behavior. Teleoperation enables remote surgical assistance where an expert surgeon guides a procedure from a different location. Single-port robotics (operating through a single small incision rather than multiple ports) is the next frontier in minimizing surgical invasiveness.

In urology, robotic prostatectomy is the standard of care, with 85%+ of prostate removals in the US performed robotically, delivering lower blood loss, shorter catheterization, and better continence and sexual function outcomes. In orthopedics, Mako enables CT-guided partial and total knee replacement with sub-millimeter accuracy, leading to better implant alignment and patient satisfaction. In gynecology, robotic hysterectomy and myomectomy provide minimally invasive alternatives to open surgery with faster recovery. In spine surgery, robotic systems guide pedicle screw placement with accuracy rates exceeding 98%, reducing the risk of nerve damage. In general surgery, robotic colorectal, hernia, and bariatric procedures are growing rapidly. Emerging applications include robotic cataract surgery (ForSight), dental implant placement (Yomi/Neocis), microsurgery for lymph node transfer and nerve repair (Microsure), and robotic bronchoscopy for lung biopsy (Auris/J&J's Monarch).

The global surgical robots market reached $14 billion in 2025 and is projected to reach $27 billion by 2030, growing at approximately 15% CAGR. Intuitive Surgical alone generated $8.4 billion in 2024 revenue, representing 17% year-over-year growth. The market spans general surgery (Intuitive dominance), orthopedics (Stryker Mako), spine (Globus Medical, Mazor), neurosurgery, and the emerging specialties of ophthalmology, dental, and microsurgery. Revenue comes from both system sales ($1-2 million per platform) and the higher-margin recurring revenue from instruments and accessories consumed during each procedure.